I t is well known that patients with bilateral pars defects have a greater degree of disc degeneration and risk the development of spondylolysis. We also know that there is a relationship between pelvic incidence, sacral slope, and pelvic tilt with spondylolysis. In terms of instability with or without spondylolysis, it is thought that L4-L5 is inherently more mobile than L5-S1 due to the ligamentous attachments to L5 (iliolumbar) and the fact that L4-L5 often sits above the intercrestal line. Generally, spondylolysis makes a motion segment more unstable. Finally, it is generally agreed upon that increased instability begets increased disc degeneration.
Where Do We Need To Go?
We need to better understand the causes and contributors to spondylolysis and spondylolisthesis at any level of the spine. The factors that should be explored include pelvic and lumbar sagittal and morphometric parameters, genetic predisposition of patients, patient risk factors, and level of disease (as was done in the present study). It would be wonderful to have the ability to council families at risk regarding activity avoidance or modification. Equally important would be to have an effective (and cost-effective) earlywarning system that would detect those at risk with high sensitivity and specificity, which might allow us to consider interventions that could avert more serious symptoms (and larger surgical procedures) later.
How Do We Get There?
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When I say ''population studies,'' it is generally accepted that we could only gain a captured population to study, as is the goal of our registry housed at the Hospital for Special Surgery. We would have to follow many asymptomatic people to capture and cloister the up to 7% who will ultimately have a spondylolysis.
Congratulations to the authors for studying this cloistered group of patients and gleaning the information they did.
